Antihypertensive drugs and risk of COVID-19?
Christopher J. Tignanelli, Nicholas E. Ingraham, Matthew A. Sparks, Ronald A. Reilkoff, Tamara Bezdicek, Bradley Benson, Timothy W. Schacker, Jeffrey G. Chipman, Michael A. Puskarich
Topics & Concepts
MedicineAtrial fibrillationInternal medicineCardiologyCoronary artery diseaseDiabetes mellitusAngiotensin IIAdverse effectAngiotensin-converting enzymeAngiotensin-converting enzyme 2Renin–angiotensin systemCoronavirus disease 2019 (COVID-19)DiseaseEndocrinologyReceptorBlood pressureInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCardiac electrophysiology and arrhythmias